<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/css" href="https://imcjms.com/public/assets/rss.css" ?><rss version="2.0">
<channel>
    <title>IMC Journal of Medical Science</title>
    <link>https://imcjms.com/public</link>
    <description>Ibrahim Medical College Journal of Medical Science</description>

                        <item>
                <title><![CDATA[Hypothyroidism and hyperprolactinemia in women
with primary and secondary infertility]]></title>

                                    <author><![CDATA[Shamima Bari]]></author>
                                    <author><![CDATA[Rokeya Begum]]></author>
                                    <author><![CDATA[Qazi Shamima Akter]]></author>
                
                <link data-url="https://imcjms.com/public/registration/journal_full_text/344">
    https://imcjms.com/public/registration/journal_full_text/344
</link>
                <pubDate>Sun, 10 May 2020 23:54:22 +0000</pubDate>
                <category><![CDATA[Original Article]]></category>
                <comments><![CDATA[IMC J Med Sci 2020; 14(1): 009]]></comments>
                <description>Abstract
Background and
objectives: Infertility is a global health problem including Bangladesh. Altered
thyroid and prolactin levels have been implicated as a cause of infertility.
The study was undertaken to find out the serum thyroid hormones and prolactin
status in women with primary and secondary infertility.
Methods:
Women with primary
and secondary infertility were enrolled. Fertile
age-matched women were included as control. The anthropometric details (age, height and weight) were recorded.
Overnight fasting blood sample was collected on 2nd day of menstrual cycle of the follicular phase. Serum thyroid
stimulating hormone (TSH),
free tri-iodothyronine (FT3) and free thyroxine(FT4) were measured by enzyme-linked
immunosorbent assay (ELISA). Serum prolactin (PRL) was estimated by
radioimmunoassay.
&amp;nbsp;Results:
A total of 150
women were enrolled in the study. Out of 150 women, 50 had primary and 50 had
secondary infertility while 50 women were age-matched fertile women as control.
The mean TSH levels of both infertility groups were significantly higher than
that of fertile women. Regarding thyroid function, 24% and 28% of women with
primary and secondary infertility had hypothyroidism respectively. The serum
prolactin level was high in 42.9% and 50% of hypothyroid cases in primary and
secondary infertility groups respectively.
Conclusion:
The study has demonstrated high occurrence of hypothyroidism with raised serum
prolactin levels among infertile females emphasizing the importance of
estimating both serum TSH and prolactin in infertility.
IMC J Med Sci 2020; 14(1): 009. EPub date: 11
May 2020.&amp;nbsp;DOI: https://doi.org/10.3329/imcjms.v14i1.47454  
*Correspondence: Shamima
Bari, Department of Physiology, Ibrahim Medical College, 1/A Ibrahim Sarani,
Segunbagicha, Dhaka 1000, Bangladesh. Email: shamima.bari@yahoo.com
&amp;nbsp;
Introduction
Infertility is an important health problem in Bangladesh. In
Bangladesh, the rate of infertility has been reported as 4% to 15% [1-4]. The
alteration of thyroid functions is associated with infertility [5-13]. Thyroid
hormones, especially thyroid stimulating hormone (TSH), have been considered as
an important component of infertility. Women with hyperprolactinemia have been
found to have primary hypothyroidism. Thyroid dysfunctions interfere with numerous
aspects of reproduction and pregnancy. Several articles have highlighted the
association of hypothyroidism or hyperthyroidism with menstrual disturbance,
anovulatory cycles, decreased productiveness and increased morbidity during
pregnancy [8-10,14,15]. Hypothyroidism itself may contribute to infertility
since thyroid hormones are necessary for the maximum production of both
estradiol and progesterone [12,13]. Hence, it is necessary to screen serum
thyroid hormones along with prolactin in women with infertility problems.
Therefore, the present study was undertaken to determine the status
of thyroid function in women with infertility.
&amp;nbsp;
Methods
Study design: Women
with primary and secondary infertility were included in the study. Equal number
of age-matched apparently healthy fertile women was enrolled as control.
Primary infertility denoted those women who had never conceived. Secondary
infertility was defined as the same condition developing after initial phase of
fertility that means the woman conceived previously but failed to conceive
subsequently [12]. The fertility was defined as the capacity to conceive. 
Infertile women having husbands with normal semen analysis and
those women with normal genitalia, uterus and adnexa were included. Women with
tubal factor, congenital anomaly of urogenital tract and any obvious organic
lesion or pelvic inflammatory diseases, and lactating women and also infertile
women with subclinical hypothyroidism, secondary hypothyroidism were and
subclinical hyperthyroidism, secondary hyperthyroidism were excluded from this
study; only primary hypothyroidism and primary hyperthyroidism were included.
The purpose and benefits of the study were explained to each
participant and informed written consent was taken from each of them. A
detailed medical, drug, personal, family, socio-economic histories were
recorded in a predesigned questionnaire. The study was approved by the Institutional
Ethical Review Committee.
Collection of
blood and estimation of biochemical parameters:
Aseptically 5 milliliter of blood was collected from cubital vein of each
participant. Blood was allowed to clot for 30-60 minutes at room temperature
and then centrifuged at 3000 rpm for 5-10 minutes. The serum was separated and
preserved at -20°C for estimation of serum TSH, FT4, FT3 and prolactin. The thyroid
hormones were measured by enzyme-linked
immunosorbent assay (ELISA) and serum prolactin was estimated by
radioimmunoassay. The analysis was done within 2 weeks of blood
collection. The normal range of serum, TSH, FT4, FT3 and prolactin were 0.3-4.0
mIU/L, 10.3-24.5 pmol/L, 2.3-6.3 pmol/L and 2-25 ng/ml respectively.
Operational definition:
The study population was categorized as (a) euthyroidism when the values of TSH
and FT4 were within the normal range, (b) hypothyroidism when the TSH value
exceeded 4.0 mIU/L and the FT4 value was normal or low, and (c) hyperthyroidism
when the TSH value was &amp;lt;0.1 mIU/L or undetectable and normal or elevated FT3
or FT4 value [16,17].
Statistical Analysis: The data
were analyzed by appropriate statistical tests namely, one way ANOVA, Tukey’s
HSD post-hoc test and unpaired student’s t test and Z test.
&amp;nbsp;
Results
A total of 150 women were included in the study. Out of 150
enrolled participants, 50 had primary (Group A) and another 50 had secondary
infertility (Group B). Fifty age-matched apparently healthy fertile women were
enrolled as control (Group C). The age range of the study population was from
23 years to 34 years and the mean age of different groups was almost similar
and no statistically significant difference was observed. There was no
significant difference of mean body mass index (BMI) between Group A and B.
The mean serum levels of TSH, FT4, FT3 and prolactin of Group A, B
and C are shown in Table-1. The mean serum TSH levels of women with primary
(4.83±0.54 mIU/L)and
secondary (6.40 ±0.59 mIU/L) infertility were significantly (p&amp;lt;0.001) higher
than that of women with normal fertility (1.98±0.18 mIU/). The mean serum FT4 levels of women
with primary (10.54±0.66
pmol/L)
and secondary (7.64±0.44
pmol/L) infertility were significantly (p&amp;lt;0.005) lower than
that of women with normal fertility (14.48±0.64 pmol/L). The mean serum FT3 levels of women
with primary (4.12±0.32
pmol/L) and secondary infertility (3.9±0.23
pmol/L) were significantly (p=0.03 and p=0.001) lower than that of
women with normal fertility (4.93±0.20
pmol/L). There was no significant difference of serum FT3 between
Group A and B. Mean serum prolactin levels of women with primary (14.54±1.23
ng/ml) and secondary (15.36±1.02 ng/ml) infertility were significantly (p&amp;lt;0.05)
higher than that of women with normal fertility (10.58±0.71 ng/ml). However, no
significant difference was observed between women with primary and secondary
infertility.
&amp;nbsp;
Table-1:
Serum TSH, FT4, FT3 and prolactin levels
of study population
&amp;nbsp;
&amp;nbsp;
According to the thyroid function status, 70% and 72% of the women
having primary and secondary infertility were euthyroid respectively while 28%
and 24% were suffering from hypothyroidism (Table-2). All the women in control
group were euthyroid. Primary hyperthyroidism was present in 2% and 4% women
with primary and secondary infertility (Table-2). The mean serum TSH level of
hypothyroidism cases (7.97±0.72
mIU/L) of secondary infertility was significantly higher (p=0.02)
compared to hypothyroidism cases of primary infertility group (5.14 ±0.85 mIU/L). High serum prolactin level was
observed in 42.9% and 50% cases with hypothyroidism of women with primary and
secondary infertility.
&amp;nbsp;
Table-2: Thyroid function
status and prolactin levels in women with primary and secondary infertility
&amp;nbsp;
&amp;nbsp;
The Pearson’s correlation coefficient was calculated for serum TSH
and prolactin in primary and secondary infertile women. In primary infertile
women serum prolactin levels were significantly positively correlated with
corresponding TSH levels (r =0.941, p &amp;lt;0.001; Figure-1). In secondary
infertile women, serum prolactin levels also showed significantly positive
correlation with serum TSH levels (r=0.915, p&amp;lt; 0.001, Figure-2). Hence,
there was a strong association observed in primary and secondary infertile
women with hyperprolactinemia and hypothyroidism.
&amp;nbsp;
Figure-1:
Correlation of serum prolactin with TSH
in primary infertile women
&amp;nbsp;
&amp;nbsp;
Figure-2: Correlation of serum
prolactin with TSH in secondary  infertile women
&amp;nbsp;
&amp;nbsp;
Discussion
Thyroid dysfunction and alteration of prolactin levels have been
reported as the cause of female infertility [8-10,15,18-23]. In the present
study, hypothyroidism was found in 24%-28% women with primary and secondary
infertility. Such pattern of thyroid dysfunction was also reported by several
studies [8-15,18,20-22,24]. In
hypothyroidism, increased thyrotropin-releasing hormone (TRH) production
stimulates both TSH and prolactin secretion [23] and that leads to
hyperprolactinemia and altered gonadotropin-releasing hormone (GnRH) secretion.
This leads to a delay in luteinizing hormone (LH) response and inadequate
corpus luteum leading to abnormal follicular development and ovulation [8-15,18,20-24].
2.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Farely TMM,
Baisey EM. The prevalence of an etiology of infertility. Proceedings of the 1st
African Population Conference. 28 November 1998; Senegal, Dakar; 1998
4.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Vaessen M. Childlessness and infecundity. WFS Comparative Studies, Series 31.
Voorburg, The Netherlands: Cross National Summaries, 1984.
6.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Roupa Z,
Polikandrioti M, Sotiropoulou P, Faros E, Koulouri A, Wozniak G. Causes of
infertility in women at reproductive age. Health Sci J. 2009; 3:
80-87.
8.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Akhter N,
Hassan, MA. Subclinical hypothyroidism and hyperprolactinaemia in infertile
women: Bangladesh perspective after universal salt iodinisation. The
internet J Endocrinol. 2009; 5(1): 1-5.
10.&amp;nbsp; Tasneem A,
Fatima I, Ali A, Mehmood N, Amin MK. The incidence of hyperprolactinaemia and
associated hypothyroidism: local experience from Lahore. Pak J Nuclear Med.
2011; 1: 49-55.
12.&amp;nbsp; Doufas AG,
Mastorakos G. The hypothalamic-pituitary-thyroid axis and the female
reproductive system. Ann N Y Acad Sci.
2000; 900(1): 65-76.
14.&amp;nbsp; Iris A, Kawuwa
MB, Habu SA, Adebayo A. Prolactin levels among infertile women in Maiduguri,
Nigeria. Trop J Obs Gyn. 2003; 20: 97-100.
17.&amp;nbsp; Jameson J.
Disorders of the thyroid gland. In: Fauci A, Braunwald E, Kasper D, Houser S,
Longo D, Jameson J, editors. Harrison&#039;s Principles of
Internal Medicine. New York: McGraw-Hill; 2008. pp. 2224-2246.
19.&amp;nbsp; Choudhary SD,
Goswami A. Hyperprolactinemia and reproductive disorders – a profile from north
east. J Assoc Phy India. 1995; 43: 617-618.
21.&amp;nbsp; Pratibha D,
Govardhani M, Krihna PT. Prolactin levels in infertility and bromocriptine
therapy in hyperprolactinemia. J Indian
Med Assoc. 1994; 92(12): 397-399.
23.&amp;nbsp; Mancini T,
Casanueva FF, Giustina A. Hyperprolactinemia and prolactinomas. Endocrinol
Metab Clin North Am. 2008; 37(1): 67-69.
25.&amp;nbsp; Elahi S,
Tasneem A, Nazir I, Nagra SA, Hyder SW. Thyroid dysfunction in infertile women.
J Coll Physicians Surg Pak. 2007; 17(4): 191-194.
27.&amp;nbsp; Armada-Dias L,
Carvalho JJ, Breitenbach MM, Franci CR, Moura EG. Is the infertility in
hypothyroidism mainly due to ovarian or pituitary functional changes? Braz J Med Biol Res. 2001; 34 (9): 1209.
29.&amp;nbsp; Goswami B,
Patel S, Chatterjee M, Koner BC, Saxena A. Correlation of prolactin and thyroid
hormone concentration with menstrual patterns in infertile women. J Reprod
Infertil. 2009; 10(3): 207-212.
31.&amp;nbsp; Verma I, Sood
R, Juneja S, Kaur S. Prevalence of hypothyroidism in infertile women and
evaluation of response of treatment for hypothyroidism on infertility. Int J Appl Basic Med Res. 2012; 2(1): 17-19.</description>

            </item>
            
    <copyright>2026 Ibrahim Medical College. All rights reserved.</copyright>
</channel>
</rss>
